ANNA STOUT-TUCKWILLER: Open Payments
NPI 1902199532 · MAXWELTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 40 payments from 11 companies in 2025. Trend: 2023 $762 · 2024 $605 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $202 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Janssen Pharmaceuticals, Inc | 4 | $101 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Neurocrine BioSciences, Inc. | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $70 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Alkermes, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
Products named: VRAYLAR, REXULTI, INGREZZA, CAPLYTA, INVEGA SUSTENNA, Auvelity, UZEDY, SPRAVATO.
Industry payments across WV — which companies pay providers there.
